Fiserv, Inc. (FI) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 22, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Fiserv, Inc. (NYSE:FI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission-form?prid=162205&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Securities Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=162207&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at

WAMCO IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Western Asset Management Company, LLC Mutual Fund Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action

NEW YORK CITY, NY / ACCESS Newswire / August 18, 2025 / WHY: New York, N.Y., August 18, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the "Western Asset US Core Bond Fund" mutual fund classes – Class I (ticker: "WATFX"), Class A (ticker: "WABAX"), Class C (ticker: "WABCX"), Class

Carbon Nanotubes Market worth $2.63 billion by 2029 at 14.9%, says MarketsandMarkets(TM)

Carbon Nanotubes Market worth $2.63 billion by 2029 at 14.9%, says MarketsandMarkets(TM) GlobeNewswire August 19, 2025 Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) — In terms of value, the Carbon Nanotubes Market size is USD 2.63 billion by 2029 from USD 1.31 billion in 2024, at a CAGR of 14.9%, as per the recent

Traction Uranium Corp. Appoints Paul Sparkes as Director

(CNSX:TRAC.CN),(OTC US:TRCTF),(Other OTC:TRCTF),(Frankfurt:Z1K), CALGARY, Alberta, Aug. 18, 2025 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction“) is pleased to announce the appointment of Paul Sparkes as Director of the Company. Mr. Sparkes is an accomplished business leader and entrepreneur with over twenty-five years of experience in media,

Traction Uranium Corp. Appoints Paul Sparkes as Director

Traction Uranium Corp. Appoints Paul Sparkes as Director GlobeNewswire August 19, 2025 CALGARY, Alberta, Aug. 18, 2025 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction“) is pleased to announce the appointment of Paul Sparkes as Director of the Company. Mr. Sparkes is an accomplished business leader and

ROSEN, LEADING INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPPI

NEW YORK CITY, NY / ACCESS Newswire / August 18, 2025 / WHY: New York, N.Y., August 18, 2025. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) between May 12, 2022 and September 22,

NVO ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Novo Nordisk A/S – September 30, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=162204&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025 (the “Class Period”), of the important September 16, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg So what: If you purchased Neogen common stock during the Class Period you may be

HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. So what: If you purchased Hims common stock

Scroll to Top